ES446906A1 - Un metodo de preparacion de cefalotina sodica, cefaloridin- betaina y cefazolina sodica, esteriles y esencialmente cris-talinas. - Google Patents

Un metodo de preparacion de cefalotina sodica, cefaloridin- betaina y cefazolina sodica, esteriles y esencialmente cris-talinas.

Info

Publication number
ES446906A1
ES446906A1 ES446906A ES446906A ES446906A1 ES 446906 A1 ES446906 A1 ES 446906A1 ES 446906 A ES446906 A ES 446906A ES 446906 A ES446906 A ES 446906A ES 446906 A1 ES446906 A1 ES 446906A1
Authority
ES
Spain
Prior art keywords
cephalosporins
parenteral administration
preparing stable
stable sterile
sterile crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES446906A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES446906A1 publication Critical patent/ES446906A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ES446906A 1975-04-11 1976-04-10 Un metodo de preparacion de cefalotina sodica, cefaloridin- betaina y cefazolina sodica, esteriles y esencialmente cris-talinas. Expired ES446906A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/567,224 US4029655A (en) 1975-04-11 1975-04-11 Method of preparing stable sterile crystalline cephalosporins for parenteral administration

Publications (1)

Publication Number Publication Date
ES446906A1 true ES446906A1 (es) 1977-05-16

Family

ID=24266257

Family Applications (1)

Application Number Title Priority Date Filing Date
ES446906A Expired ES446906A1 (es) 1975-04-11 1976-04-10 Un metodo de preparacion de cefalotina sodica, cefaloridin- betaina y cefazolina sodica, esteriles y esencialmente cris-talinas.

Country Status (11)

Country Link
US (2) US4029655A (enExample)
JP (1) JPS51123813A (enExample)
BE (1) BE840280A (enExample)
CA (1) CA1068680A (enExample)
DE (1) DE2614668C2 (enExample)
ES (1) ES446906A1 (enExample)
FR (1) FR2306993A1 (enExample)
GB (1) GB1537874A (enExample)
IE (1) IE42955B1 (enExample)
IL (1) IL49073A (enExample)
NL (1) NL7603659A (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996355A (en) * 1975-01-02 1976-12-07 American Home Products Corporation Permanent suspension pharmaceutical dosage form
IL53427A0 (en) * 1976-11-24 1978-01-31 Lilly Co Eli Method of preparing a rapidly dissolving powder of sterile crystalline cefozolin sodium for parenteral administration
US4115644A (en) * 1977-09-19 1978-09-19 Eli Lilly And Company Process for preparing pure cefamandole from alkali metal and ammonium salts thereof
US4132848A (en) * 1977-11-03 1979-01-02 Eli Lilly And Company Method of preparing a rapidly dissolving powder of crystalline cephalothin sodium for parenteral administration
FR2421905A1 (fr) * 1977-11-24 1979-11-02 Lilly Co Eli Preparation d'une poudre de cephalothine-sodiu m stable, pour administration parenterale
JPS54147917A (en) * 1978-05-08 1979-11-19 Sumitomo Chem Co Ltd Ferrze-drying method
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
JPS60120886A (ja) * 1983-12-02 1985-06-28 Takeda Chem Ind Ltd セフェムカルボン酸のナトリウム塩の結晶
JPH06786B2 (ja) * 1984-02-22 1994-01-05 塩野義製薬株式会社 セフアロチンナトリウムの結晶性凍結乾燥製剤の製造法
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
US4714760A (en) * 1985-08-20 1987-12-22 Bristol-Myers Company Cephalosporin intermediates
US4808617A (en) * 1985-12-18 1989-02-28 Bristol-Myers Company Lyophilized or precipitated cephalosporin zwitterion and salt combination
GB8808433D0 (en) * 1988-04-11 1988-05-11 Merck Sharp & Dohme Therapeutic agents
TW264475B (enExample) * 1991-09-20 1995-12-01 Takeda Pharm Industry Co Ltd
US6111098A (en) * 1994-05-02 2000-08-29 Shionogi & Co., Ltd. Crystal of pyrrolidylthiocarbapenem derivative, lyophilized preparation containing said crystal, and process for producing the same
DE602005002742T2 (de) * 2004-04-22 2008-01-24 Pfizer Products Inc., Groton Verfahren zur stabilisierung von ungeordnetem cefovecin-natriumsalz
CN101759708B (zh) * 2008-12-23 2012-07-04 深圳信立泰药业股份有限公司 头孢地嗪钠晶型及其制备方法和含有该晶型的药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3085884A (en) * 1958-07-28 1963-04-16 Liquefreeze Company Inc Method of freezing and shipping foodstuffs
GB1234802A (en) * 1968-04-19 1971-06-09 British American Tobacco Co Improvements relating to the packing of liquids
US3725003A (en) * 1969-11-04 1973-04-03 Moore Perk Corp Method of sterile packaging

Also Published As

Publication number Publication date
CA1068680A (en) 1979-12-25
IL49073A (en) 1979-03-12
BE840280A (fr) 1976-10-01
DE2614668C2 (de) 1986-10-30
DE2614668A1 (de) 1976-10-21
US4104391A (en) 1978-08-01
IL49073A0 (en) 1976-04-30
JPS6143356B2 (enExample) 1986-09-26
NL7603659A (nl) 1976-10-13
JPS51123813A (en) 1976-10-28
FR2306993B1 (enExample) 1978-11-17
GB1537874A (en) 1979-01-04
IE42955L (en) 1976-10-11
FR2306993A1 (fr) 1976-11-05
US4029655A (en) 1977-06-14
IE42955B1 (en) 1980-11-19

Similar Documents

Publication Publication Date Title
ES446906A1 (es) Un metodo de preparacion de cefalotina sodica, cefaloridin- betaina y cefazolina sodica, esteriles y esencialmente cris-talinas.
GB2051665B (en) Solvent stretch process for preparing microporous films from precursor films of controlled crystalline structure
ES464412A1 (es) Un procedimiento para la preparacion de cefazolina sodica, esencialmente cristalina y rapidamente soluble.
ES476553A1 (es) Procedimiento para eliminar azucares flatulentos de la soja.
ES8404999A1 (es) Un procedimiento para preparar acido l-ascorbico.
ES443835A2 (es) Un procedimiento para la preparacion de la forma de alto punto de fusion del acido quenodesoxicolico.
BG49615A3 (bg) Метод за получаване на производни на 3-заместени тиометилцефало- спорини или техни етилови, или дифенилетилови естери, или техни соли
DE3372294D1 (en) Process for the preparation of isomaltulose (6-0-alpha-d-glucopyranosido-d-fructose) using immobilized bacterial cells
YU242787A (en) Process for obtaining crystalline cephadroxyl monohydrate
ES455069A1 (es) Un procedimiento para la preparacion de una cefazolina sodi-ca esencialmente amorfa, esteril, para su reconstitucion para la administracion parenteral.
IE41371L (en) Lincomycin production
US2424832A (en) Process for producing penicillin
GB977933A (en) Thick web dendritic growth
ZA805152B (en) Insulin crystal suspension and process for the preparation thereof
US3664926A (en) Crystallization of l-asparaginase
ES461983A1 (es) Un procedimiento para la preparacion de nuevas cefalospori- nas.
JPS6424098A (en) Heat treatment of compound semiconductor single crystal
GB1394849A (en) 5-dihydrocoriolin c and process for producing the same
GB1111511A (en) Novel antibiotic substances sugordomycins, and a process for the manufacture thereofand an analogue sugordomycin
UA19919A1 (uk) Спосіб вирощуваhhя кристалів коруhда
JPS51138603A (en) Process for preparing n-ac etyle-dl-amino acids
JPS51136582A (en) Process for production of a semi -conductor crystal
SU596616A1 (ru) Способ получени кристаллической гуанил-рибонуклеазы
JPS5250164A (en) Process for production of semiconductor single crystal
JPS5249999A (en) Method for growth of (gaal)as crystal

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19890206